The American Heart Association (AHA) adopted new recommendations in January for women with congenital heart defects who wanted to have children. A Washington Post article examines the case of one mother who may otherwise been unable to survive her pregnancy.

Englishman John McCafferty holds the record as the world's longest surviving heart transplant patient. At the time of his surgery in the fall of 1982, physicians estimated he’d live five years. He lived another 30 on top of that—working, enjoying family, running half marathons, traveling, fundraising for a transplant support charity and trout fishing—before passing away just last summer.

Memphis, in the heart of the stroke belt, has a new weapon in decreasing the time it takes to deliver life-saving care.

Researchers at the Weizmann Institute of Science in Israel have uncovered a molecule found in newborns that aids in regenerating damaged hearts—and are now testing ways that the molecule could treat heart attack victims.

Researchers from the University of New South Wales in Sydney, Australia, announced new findings that suggest smaller doses of a few blood pressure medications could be just as effective as standard doses of just one.

Researchers from Rice University and the Texas Heart Institute are introducing a wireless pacemaker that can be implanted directly into a patient’s heart at this week's IEEE’s International Microwave Symposium in Honolulu, running through June 9.

The U.S. Food and Drug Administration (FDA) approved an expanded indication for the Sapien 3 Transcatheter Heart Valve, a move that will allow physicians to use the device to better treat patients with symptomatic heart disease.

St. John Hospital & Medical Center became the first facility in the United States to treat a high-risk patient with a heart pump and newly approved Tryton Side Branch Stent.